Ethyl 4-(methylthio)butyrate
| Common Name: |
Ethyl 4-(methylthio)butyrate |
| IUPAC Name: |
ethyl 4-methylsulfanylbutanoate |
| Molecular Formula: |
C7H14O2S |
| SMILES: |
CCOC(=O)CCCSC |
| Inchi: |
InCh1S/C7H14O2S/c1-3-9-7(8)5-4-6-10-2/h3-6H2,1-2H3I |
| Inchi Key: |
QNLREUZIHJHXRK-UHFFFAOYSA-N |
| Cas No: |
22014-48-8 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
162.25 |
| Mass (g/mol) |
162.071 |
| Molar Refractivity |
44.64 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
6 |
| Rings |
|
| TPSA |
51.60 |
| Hetero Atoms |
3 |
| Heavy Atoms |
10 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
95.00 @ 15.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
0.108 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.86 |
| LogP |
1.693 |
| iLOGP |
2.05 |
| XLOGP3 |
1.76 |
| WLOGP |
1.69 |
| MLOGP |
1.63 |
| ESOL Log S |
-1.56 |
| ESOL Solubility (mg/ml) |
4.48 |
| ESOL Solubility (mol/l) |
0.028 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-2.46 |
| Ali Solubility (mg/ml) |
0.56 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.06 |
| Silicos-IT Solubility (mg/ml) |
1.4 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.04 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.581 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.07 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
